Apollo Hospitals Grasim Varun Beverages Among BSE 100 Stocks Hitting 52Week Highs ADP Reports Private Payrolls Rise by 109000 in April Topping Expectations Ping An Biomedical Secures Nasdaq Extension for Minimum Bid Compliance Oppenheimer Upgrades Quanta Services Stock Rating on Infrastructure Growth Prospects US Wholesale Inflation Accelerates to 6 Annually in April Highest Since 2022 Susquehanna Boosts Alibaba Price Target to 185 Amid Renewed Growth Optimism AXR Q1 2026 Earnings Earnings Per Share Slightly Ahead of Estimates Stock Rises AII Q1 2026 Earnings Earnings Beat Expectations Amid Strong Underwriting Performance SABS Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development Shares Edge Higher SUPV Q1 2026 Earnings Massive EPS Surprise of 27047 as Company Reverses Loss Expectations HSDT Q1 2026 Earnings Significant EPS Miss Raises Concerns PKX Q4 2025 Earnings Massive EPS Miss Exceeds Negative Surprise Amidst Challenging Conditions Granite Point Mortgage Trust GPMT Edges Higher as Shares Test Key Resistance at 147 Annexon Inc ANNX Holds Steady Near Support After Marginal Decline Greenwave Technology Solutions GWAV Slips 382 as Selling Pressure Tests Key Support Friedman Industries FRD Shows Subtle Decline Tests Critical Support Zone DDC Enterprise Limited DDC Slides 4 Amid Selling Pressure Key Support in Focus EUs E6 Nations Seek Unified Stance on Capital Market Supervision FORR Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Reacts Positively Adamas Trust Preferred ADAMM Edges Lower as Yield Seekers Eye Narrow Trading Range IDCC Q1 2026 Earnings EPS Surges Past Estimates on Strong Licensing Revenue Stock Declines GPMT Q1 2026 Earnings NarrowerThanExpected Loss Signals Potential Stabilization CLAR Q1 2026 Earnings EPS Beats Estimates but Stock Declines ASND Q1 2026 Earnings Wide EPS Miss as Ascendis Pharma Remains PreRevenue Stock Edges Higher CBAN Q1 2026 Earnings Earnings Fall Short of Estimates as EPS Misses by 1777 GNS Q4 2022 Earnings Massive EPS Miss as Company Posts Heavy Loss Teva Q1 2026 Earnings Strong EPS Beat on Cost Discipline Shares Edge Higher